20 participants
Safety and Dose Study of GRN163L Administered to Treat Patients With Refractory or Relapsed Multiple Myeloma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2015-12-24
- Start Date:
- 2007-11-30
- Completion:
- 2011-07-31
Conditions
- Multiple Myeloma
Interventions
- DRUG
No Results Yet